Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy with a poor prognosis,
and there is little data available from the Chinese population. This retrospective study …

Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy associated with
HTLV-1 infection. To decipher the genetic landscape of ATL, we performed an integrated …

Background Adult T-cell leukemia/lymphoma (ATLL) is aggressive mature T-cell
lymphoproliferative disorder with a poor outcome. Methods We present 10 patients with …

Purpose The purpose of this study is to perform a retrospective analysis of disease
outcomes and mutational profiles in patients with adult T-cell lymphoblastic lymphoma (T …

Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a clinically aggressive and
heterogeneous entity; hence it is likely that different variants of ATLL have different …

Objective Despite the remarkable advances in chemotherapy and allogeneic hematopoietic
stem cell transplantation (HSCT), adult T-cell leukemia-lymphoma (ATL) is still associated …

Adult T-cell leukemia lymphoma (ATLL) is a rare T cell neoplasm that is endemic in
Japanese, Caribbean, and Latin American populations. Most North American ATLL patients …

Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell neoplasm with a dismal
prognosis. This disease is caused by human T-cell leukemia virus type-1 (HTLV-1) …

Adult T‐cell leukemia/lymphoma (ATL) is a mature T‐cell neoplasm and is classified into
four subtypes (acute, lymphoma, chronic, and smoldering) according to the Shimoyama …

Adult T-cell leukemia/lymphoma (ATLL) is a rare and aggressive disease caused by human
T-cell lymphotropic virus type 1 that predominantly affects Japanese and Caribbean …